Prof. Cheung Yin Ting

About me

CHEUNG Yin Ting 張彥婷

B.Sc. (Pharm.) (Hons.), Ph.D.
Associate Director (Research)
Associate Professor
School of Pharmacy
Faculty of Medicine
The Chinese University of Hong Kong

Tel: (852) 3943 6833
Fax:(852) 2603 5295
Email: yinting.cheung@cuhk.edu.hk

Personal Details

Cheung Yin Ting received her training on pharmacoepidemiology and cancer survivorship from the National University of Singapore (NUS) and St. Jude Children’s Research Hospital (Memphis, USA). During her Ph.D. candidature, she had the privilege of pioneering the cognitive and psychosocial research program in Asian breast cancer patients. Her work with the Cognitive Neuroscience Team at St. Jude involved characterizing the pharmacological, biological and genetic determinants of brain function and other treatment-related complications in survivors of pediatric cancer. She also had previous teaching appointments with Rhodes College (Memphis, USA) as an Adjunct Assistant Professor.

Yin Ting joined the School of Pharmacy at the Chinese University of Hong Kong in August 2017. Yin Ting has initiated research/ commissioned projects for the Childhood Cancer Survivors’ Study (National Institute of Health, USA), the Chinese Children’s Cancer Group (CCCG), the Multinational Association for Supportive Care in Cancer (MASCC) and the Hospital Authority, as well as NGOs serving patients with cancer. She hopes that her collaborative research with students, clinicians and scientists can help to improve health outcomes in survivors of cancer and other chronic diseases.

Currently, Yin Ting is an expert member on the Children’s Oncology Group (Neuropsychology Panel), and the Secretariat of the Patient Partnership Committee of the Multinational Association for Supportive Care in Cancer. She also serves as Deputy Chairman of the HA Central Institutional Review Board (Paediatrics Panel) and member of the Pharmacy and Poisons (Registration of Pharmaceutical Products and Substances: Certification of Clinical Trial/Medicinal Test) Committee.

**Seeking motivated MPhil/PhD candidates who wish to pursue a higher degree in cancer survivorship-related research. Learning outcomes include developing integrated skills in epidemiology, biostatistics, pharmacy practice and social sciences. Candidates will have the opportunity to initiate patient-centered outcomes or/and interventional research in a collaborative environment. Please contact Dr Cheung (yinting.cheung@cuhk.edu.hk) for more information.   

Research

Research Interests

Yin Ting’s research interest is in supportive care and survivorship in adult and pediatric oncology.

Major advances in health care delivery have dramatically improved survival rates for children and adults diagnosed with cancer and other life-threatening diseases. Unfortunately, survivorship often comes at a cost of developing a myriad of treatment-related complications that can have a negative impact on their functional outcomes and health-related quality of life.

Yin Ting’s work adopts a combination of epidemiological, translational and qualitative research approaches to characterise these drug-induced toxicities, particularly in adverse outcomes related to brain function, such as neurocognitive impairment, behavioral problems and psychological distress. Her collaborative work involves evaluating how underlying genetic predispositions, as well as physiological biomarkers, biobehavioral factors and chemotherapy exposures during the active treatment phase, are predictive of long-term complications in survivors of cancer.

The eventual goal of this work is to develop an evidence-based model that will facilitate a “personalized survivorship care plan” for each cancer survivor, as well as to apply a similar approach to improve health outcomes in other chronic conditions.

Research collaborations:

  • St Jude Children’s Research Hospital (Memphis, USA)
  • Guangzhou Women and Children’s Medical Center (Guangzhou, China)
  • Childhood Cancer Survivors’ Study (CCSS) (Funded by the National Institute of Cancer, USA)
  • Chinese Children’s Cancer Group (CCCG)
  • Multinational Association for Supportive Care in Cancer (MASCC)

Grants

Research grants:

As PI

  • Hong Kong Research Grants Council (RGC)
  • Developing a Prognostic Model to Predict Inter-individual Trajectory of Functional Outcomes in Adolescents and Young Adults with Cancer (ref no: 14604022) Sponsored by Hong Kong Research Grants Council (RGC): General Research Fund (GRF) during the period 01-01-2023 to 30-09-2024 for the sum of HKD 498,000
    Role: Principal Investigator
  • The Mechanistic Role of “Premature Aging” in Cognitive and Behavioral Outcomes in Survivors of Childhood Cancer (Ref No: 14605421). Sponsored by Hong Kong Research Grants Council (RGC): General Research Fund (GRF) during the period 01-01-2022 to 30-09-2023 for the sum of HKD 522,566
    Role: Principal Investigator
  • Neuroimaging, Cognitive and Life Functioning Outcomes in Patients with Hemophilia (Ref No: 14602620). Sponsored by Hong Kong Research Grants Council (RGC): General Research Fund (GRF) during the period 01-01-2021 to 30-12-2022 for the sum of HKD 424,400
    Role: Principal Investigator
  • Health and Socio-environmental Determinants of Functional Outcomes in Survivors of Pediatric/Young Adult Bone and Soft-Tissue Sarcoma (Ref No: 14601919). Sponsored by Hong Kong Research Grants Council (RGC): General Research Fund (GRF) during the period 01-01-2020 to 31-12-2022 for the sum of HKD 634,508
    Role: Principal Investigator
  • A Biobehavioral Model to Understanding Cognitive and Psychosocial Outcomes in Young Survivors of Childhood Leukemia (ref no: 24614818) Sponsored by Research Grant Council (RGC) (Early Career Scheme) during the period 01-01-2019 to 30-6-2021 for the sum of HKD 636,835 (completed)
    Role: Principal Investigator
  • Health and Medical Research Fund (HMRF)
  • Psychosocial and functional outcomes in Chinese survivors of adolescent and young adult (AYA) cancer: a pilot study (ref no: 09202846) Sponsored by Health and Medical Research Fund (HMRF) during the period 19-09-2023 to 18-09-2024 for the sum of HKD 99,800
    Role: Principal Investigator
  • Personalized Risk-based Care and Education for Early Survivors of Childhood Cancer in Hong Kong (ref: 03170047) Sponsored by Health and Medical Research Fund (Research Fellowship) during the period 01-02-2019 to 31-07-2021 for the sum of HKD 813,070 (completed)
    Role: Principal Investigator
  • Jockey Club Charities Trust
  • Program Evaluation of the “Jockey Club Community Support for Children with Medical Complexity” (賽馬會「友晴同路」社區支援服務) (S/N 2022-0134). Sponsored by the Jockey Club Charities Trust (in collaboration with the Hong Kong Sheng Kung Hui Welfare Council Limited) during the period 01-04-2023 to 31-12-2025 for the sum of HKD 160,000
    Role: Site Principal Investigator

  • “Eyes on Haemo” – A Self-Management Multi-modal Care Program (<凝‧視血友>自我管理計劃 ) (S/N 2020-0106). Sponsored by the Jockey Club Charities Trust (in collaboration with the Hong Kong Hemophilia Society) during the period 01-10-2020 to 30-09-2025 for the sum of HKD 899,750 (of HKD 2,690,000)
    Role: Site Principal Investigator
  • Other Grants
  • Promoting Safe and Appropriate Use of TCM in Survivors of Childhood Cancer (促進兒童癌症康復者安全有效使用中醫藥的知識) (19B1‐2/017A_R1). Sponsored by Chinese Medicine Development Fund (中醫藥發展基金) during the period 01-01-2021 to 31-12-2021 for the sum of HKD 65,200 (completed)
    Role: Principal Investigator

As Co-I

  • Health and Medical Research Fund (HMRF)
  • Effects of immersive virtual reality for alleviating anxiety, nausea and vomiting among paediatric cancer patients receiving their first chemotherapy: a randomized controlled trial. (Ref: 18190151). Sponsored by Health and Medical Research Fund (HMRF) during the period 01-02-2022 to 31-01-2025 for the sum of HKD 983,851
    Role: Co-investigator (PI: Prof Cho Lee Wong, CUHK Nethersole School of Nursing)
  • Iron Deficiency and its Impact on Neurocognitive Function in Hong Kong Adolescents (Ref: 17180441). Sponsored by Health and Medical Research Fund (HMRF) during the period 01-08-2020 to 31-12-2021 for the sum of HKD 594,820 (completed)
    Role: Co-investigator (PI: Prof Chi-Kong Li, CUHK Paediatrics)
  • Other Grants
  • Promoting Safe and Appropriate Use of TCM in Survivors of Adolescent and Young Adult Cancers (中醫藥與青少年和青年癌症康復者(15-39歲)推廣計劃) (21B1-2/014A_R1). Sponsored by Chinese Medicine Development Fund (中醫藥發展基金) during the period 01-05-2023 to 30-04-2024 for the sum of HKD 750,000 (completed)
    Role: Co-investigator (PI: Dr. Katy Koon, CUHK School of Chinese Medicine)
  • Understanding the Experience of Cancer Survivorship among Adolescent Cancer Survivors and Their Parents through Camera Lenses: A Photovoice Study. Sponsored by Nethersole Institute of Continuing Holistic Health Education (NICHE) Research Grant during the period of 1-2-2022 to 31-1-2023 for the sum of HKD 115,000
    Role: Co-investigator (PI: Prof Cho Lee Wong, CUHK Nethersole School of Nursing)

Teaching grant:

  • Courseware Development Grant Scheme
  • Prescribing in Practice in special patient populations: a case-illustrated project-based learning for medical and pharmacy students. Sponsored by the CUHK Courseware Development Grant Scheme 2019-2022 during the period of 01-01-2021 to 30-11-2021.
    Role: Project team member (PI: Prof Elaine Chow, CUHK Medicine and Therapeutics)
  • Other Grants
  • A Recorded Objective Structured Clinical Examination (OSCE): Mixed eLearning and Face-to-face Assessment. Sponsored by the CUHK Special Funding Scheme for Online Learning 2019-2022 during the period of 01-05-2020 to 28-02-2021 (Completed)
    Role: Project team member (PI: Prof Teddy Lam, CUHK Pharmacy)

Teaching

Teaching

Bachelor of Pharmacy Programme

  • PHAR 1000 Introduction to Pharmacy
  • PHAR 2710 Pharmaceutical Research Methods
  • PHAR 3812 Clinical Assessment and Monitoring
  • PHAR 4911 (Research Project I) and PHAR4912 (Research Project II)
  • MEDF 1021 Faculty Package: Public Health & Healthcare Ethics
  • MEDF 1031 Faculty Package: Communication Skills
  • MEDF 1041 Interprofessional Healthcare

Master of Clinical Pharmacy

  • PHAR 5852 Pharmacovigilance and Public Health for Pharmacists
  • PHAR 5824 (Graduation Project I)
  • PHAR 5924 (Graduation Project II)

Publications

Representative Publications

  1. Lam CS, Zhou KR, Loong HHF, Chung VC, Ngan CK, Cheung YT. The Use of Traditional, Complementary, and Integrative Medicine in Cancer: A Data-Mining Study of One-million Online Posts from Health Forums and Social Media Platforms. J Med Internet Res. Accepted on March 13, 2023. In Press.

  2. Lam CS, Koon HK, Loong HH, Chung VC, Cheung YT. Associations of dietary supplement use with all-cause and cause-specific mortality in patients diagnosed with cancer: a large prospective cohort study in the UK Biobank. Eur J Nutr. 2023 Mar;62(2):879-889. 

  3. Prescription of psychotropic medications after diagnosis of cancer and the associations with risk of mortality in Chinese patients: A population-based cohort study. Lam CS, Lee CP, Chan JWY, Cheung YT. Asian J Psychiatr. 2022 Dec;78:103290.

  4. Ma CT, Chou HW, Lam TT, Tung YT, Lai YW, Lee LK, Lee VW, Yeung NC, Leung AW, Bhatia S, Li CK, Cheung YT. Provision of a personalized survivorship care plan and its impact on cancer-related health literacy among childhood cancer survivors in Hong Kong. Pediatr Blood Cancer. 2023 Feb;70(2):e30084

  5. Ewig CL, Hui KH, Lee SLK, Leung AWK, Wong GL, Li CK, Cheung YT. Medication Burden Among Pediatric Cancer Survivors: Analysis of a Population-Wide Electronic Database in Hong Kong. JNCI Cancer Spectr. 2022 Sep 1;6(5):pkac059.

  6. Sato S, Li N, Dixon SB, Kato M, Zhang H, Li CK, Howell RM, Leisenring WM, Bhatia S, Oeffinger KC, Armstrong GT, Yasui Y, Krull KR, Cheung YT. Functional Outcomes and Social Attainment in Asian/Pacific Islander Childhood Cancer Survivors in the United States: A Report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev. 2021 Dec;30(12):2244-2255.

  7. van der Plas E, Modi A, Li CK, Cheung YT. Cognitive Impairment in Survivors of Pediatric Acute Lymphoblastic Leukemia treated with Chemotherapy Only. J Clin Oncol. 2021 Apr 22;JCO2002322.

  8. Cheung YT, Zhang H, Cai J, Au-Duong LWP, Yang LS, Yan C, Zhou F, Chen X, Guan X, Pui CH, Hudson MM, Li CK. Identifying Priorities for Harmonizing Guidelines for the Long-term Surveillance of Childhood Cancer Survivors in the Chinese Children Cancer Group (CCCG). JCO Global Oncology. 2021;7:261-276.

  9. Peng L, Yam PPY, Yang LS, Lam CS, Chan AS, Li CK and Cheung YT. Neurocognitive and Behavioral Outcomes of Chinese Survivors of Childhood Lymphoblastic Leukemia. Front Oncol 2021 Apr 20;11:655669.

  10. Cheung YT, Liu W, Brinkman TM, Srivastava D, Leisenring WM, Howell RM, et al. Prescription Psychoactive Medication Use in Adolescent Survivors of Childhood Cancer and Association with Adult Functional Outcomes. JNCI Cancer Spectrum 2020. Epub: pkaa057, https://doi.org/10.1093/jncics/pkaa057

  11. Yan C, Cheung RSY, Wong CL, Cheng HY, Liu F, Huang H, Ewig CLY, Li CK, Zhang H*, Cheung YT*. Stress and Perception of Procedural Pain Management in Chinese Parents of Children With Cancer. J Pain Symptom Manage. 2020 Jul 5;S0885-3924(20)30571-6. *co-corresponding authors

  12. Cheung YT, Eskind A, Inaba H, Hudson MM, Pui CH, Krull KR, Wolf J. Association of Bacteremic Sepsis With Long-term Neurocognitive Dysfunction in Pediatric Patients With Acute Lymphoblastic Leukemia. JAMA Pediatrics. 2018 Sep 24. doi: 10.1001/jamapediatrics.2018.2500.

  13. Cheung YT, Khan RB, Liu W, Brinkman TM, Edelmann MN, Reddick WE, Pei D, Panoskaltsis-Mortari A, Srivastava D, Cheng C, Robison LL, Hudson MM, Pui CH, Krull KR. Association of Cerebrospinal Fluid Biomarkers of Central Nervous System Injury With Neurocognitive and Brain Imaging Outcomes in Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia. JAMA Oncology 2018 Jul 12;4(7):e180089.

  14. Cheung YT, Brinkman TM, Li CH, Mzayek Y, Srivastava D, Ness KK, Patel SK, Howell RM, Oeffinger KC, Robison LL, Armstrong GT, Krull KR. Chronic Health Conditions and Neurocognitive Function in Aging Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study. Journal of National Cancer Institute. 2017. 2018;110(4):411-419.

More Publications

Supplementary Information

Awards

2022 The Barrie Cassilieth Memorial New Investigator Scholarship (Awarded to PhD. Student Mr Jason Lam). Society for Integrative Oncology (SIO) Annual Meeting 2022
2022 Steven M Grunberg Memorial Award (Highest-ranking abstract). Multinational Association of Supportive Care in Cancer (MASCC) Meeting 2022. Role: Senior author
2022 Silver Award for Allied Health Oral Abstracts Category. Joint Annual Scientific Meeting of the HKPS, HKCPaed, HKPNA & HKCPN in 2022. Hong Kong Children’s Hospital.
2018 MASCC Rehab, Survivorship QoL SG Successful Training Award – PRO from The Multinational Association of Supportive Care in Cancer (MASCC)
2018 Travel Grant “Mainland and Taiwan Strategic Partnership Development Programme 2018/2019” by Office of Academic Links (China), CUHK
2013, 2015, 2017 American Society of Clinical Oncology (ASCO) Meeting, Conquer Cancer Foundation Merit Award

Media Coverage

Service and consultancy with:

NGOs serving children with cancer (Little Life Warrior Society, Children’s Cancer Foundation)

  1. Public lecture “Safe Use of Traditional Chinese Medicine in Children with Cancer<中醫藥與兒童癌症康復者>” by Dr David Au (CUHK Institute of Integrative Medicine).Hosted by Prof Cheung Yin Ting. (Supported by the Chinese Medicine Development Fund)
    Download – Traditional Chinese Medicine Booklet <下載 – 中醫藥與兒童癌症康復者小冊子> : http://bit.ly/3nOMYtZ
    YouTube: https://bit.ly/TCMTalk2021
    15 April 2021 
  2. Online educational series “Survivorship Passport for Children with Cancer <康復者計劃 – 擁有自己的康復者護照 —— 對「症」下藥,「知」多D、「做」好D健康講座>” by Prof Cheung Yin Ting.
    For the Little Life Warriors Society
    YouTube: http://bit.ly/3auDwTf
    November 2020

Hong Kong Hemophilia Society (HKHS)

  1. Public lecture “Quality of Life and Functional Outcomes in Patients with Hemophilia <血友人生>” by Prof Cheung Yin Ting.
    For the Hong Kong Hemophilia Society Annual General Meeting
    YouTube: https://youtube.com/playlist?list=PLYjhMWwbszYBMvkDpAH5XIO2vYlzPaoYm
    17 April 2021

 

Comments are closed